What is the price target for KYNB stock?
8 analysts have analysed KYNB and the average price target is 43.86 USD. This implies a price increase of 565.55% is expected in the next year compared to the current price of 6.59.
KYNTRA BIO INC (KYNB) Forecast, Price Target & Analyst Ratings
NASDAQ:KYNB • US31572Q8814
Current stock price
6.59 USD
+0.05 (+0.76%)
At close:
7.132 USD
+0.54 (+8.22%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KYNTRA BIO INC (KYNB).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$3.42
- Revenue Estimate
- 1.336M
Price Target Details & History
Consensus Price Target and Range
Mean target
$43.86
Upside
+ 565.55%
From current price of $6.59 to mean target of $43.86, Based on 8 analyst forecasts
Low
$43.43
Median
$43.86
High
$45.15
Price Target Revisions
1 Month
0.00%
3 Months
N/A
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for KYNB. The average price target is 43.86 USD. This implies a price increase of 565.55% is expected in the next year compared to the current price of 6.59.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
KYNB was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about KYNB.
In the previous month the buy percentage consensus was at a similar level.
KYNB was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$3.42
- Revenue Estimate
- 1.336M
- Revenue Q2Q
- -51.22%
- EPS Q2Q
- -373.77%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
-13.25%
Revenue (3 Months)
N/A
EPS (1 Month)
21.79%
EPS (3 Months)
N/A
Next Earnings Summary
KYNB is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -3.42 USD and the consensus revenue estimate is 1.34M USD.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 46.803M -66.74% | 29.621M -36.71% | 6.44M -78.26% | 6.222M -3.39% | 5.253M -15.57% | 5.273M 0.38% | |
| EBITDA YoY % growth | -300.185M -3.37% | -128.27M 57.27% | -44.594M 65.23% | -47.226M -5.90% | -51.918M -9.94% | -57.528M -10.81% | |
| EBIT YoY % growth | -310.115M -3.03% | -130.962M 57.77% | -45.342M 65.38% | -55.335M -22.04% | -65.739M -18.80% | -73.338M -11.56% | |
| Operating Margin | -662.60% | -442.13% | -704.07% | -889.34% | -1,251.46% | -1,390.82% | |
| EPS YoY % growth | -70.00 10.83% | -12.00 82.86% | -7.49 37.58% | -12.19 -62.74% | -10.87 10.84% | -7.05 35.15% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.42 -373.77% | -3.42 -81.76% | -3.47 -6.86% | -3.50 2.94% | -2.81 18.03% | -3.02 11.64% | -2.99 13.95% | -2.96 15.57% | -2.93 -4.36% | -2.90 4.05% | -2.88 3.75% | -2.85 3.79% |
| Revenue Q2Q % growth | 1.336M -51.22% | 1.352M 0.30% | 1.265M 17.57% | 1.321M 3.36% | 1.54M 15.27% | 1.54M 13.91% | 1.54M 21.74% | 1.54M 16.58% | 1.54M | 1.54M | 1.54M | 1.54M |
| EBITDA Q2Q % growth | -14.484M -0.12% | -14.79M -33.11% | -15.402M -232.66% | -16.014M -25.39% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
1.93%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-7.82%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-7.26%
EBIT Next 5 Year
N/A
KYNTRA BIO INC / KYNB Forecast FAQ
What is the next earnings date for KYNB stock?
KYNTRA BIO INC (KYNB) will report earnings on 2026-05-11, after the market close.
What are the consensus estimates for KYNTRA BIO INC (KYNB) next earnings?
The consensus EPS estimate for the next earnings of KYNTRA BIO INC (KYNB) is -3.42 USD and the consensus revenue estimate is 1.34M USD.
What is the expected long term growth rate for KYNB stock?
The expected long term growth rate for KYNTRA BIO INC (KYNB) is -7.82%.